A detailed history of Credit Agricole S A transactions in Moderna, Inc. stock. As of the latest transaction made, Credit Agricole S A holds 300,000 shares of MRNA stock, worth $34.8 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
300,000
Previous 444,382 32.49%
Holding current value
$34.8 Million
Previous $44.2 Million 27.66%
% of portfolio
0.33%
Previous 0.51%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$85.37 - $115.44 $13.6 Million - $18.4 Million
-159,565 Reduced 68.72%
72,641 $7.74 Million
Q4 2023

Feb 13, 2024

BUY
$69.51 - $104.43 $2.72 Million - $4.08 Million
39,103 Added 20.25%
232,206 $23.1 Million
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $2.01 Million - $2.64 Million
20,869 Added 12.12%
193,103 $19.9 Million
Q2 2023

Jul 31, 2023

BUY
$118.5 - $160.53 $6.41 Million - $8.69 Million
54,113 Added 45.81%
172,234 $20.9 Million
Q1 2023

May 12, 2023

BUY
$135.66 - $197.02 $2.01 Million - $2.92 Million
14,827 Added 14.35%
118,121 $18.1 Million
Q4 2022

Feb 13, 2023

SELL
$118.38 - $210.04 $548,572 - $973,325
-4,634 Reduced 4.29%
103,294 $18.6 Million
Q3 2022

Nov 10, 2022

SELL
$118.07 - $194.18 $194,343 - $319,620
-1,646 Reduced 1.5%
107,928 $12.8 Million
Q2 2022

Aug 08, 2022

BUY
$117.13 - $176.59 $1.73 Million - $2.61 Million
14,755 Added 15.56%
109,574 $15.7 Million
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $7.05 Million - $13.1 Million
55,742 Added 142.65%
94,819 $16.3 Million
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $4.79 Million - $7.81 Million
21,196 Added 118.54%
39,077 $9.93 Million
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $1.11 Million - $2.41 Million
4,982 Added 38.62%
17,881 $6.88 Million
Q2 2021

Aug 10, 2021

SELL
$129.91 - $234.98 $856,236 - $1.55 Million
-6,591 Reduced 33.82%
12,899 $3.03 Million
Q1 2021

May 17, 2021

BUY
$109.18 - $185.98 $2.1 Million - $3.57 Million
19,190 Added 6396.67%
19,490 $2.55 Million
Q4 2020

Feb 12, 2021

SELL
$65.74 - $169.86 $295,830 - $764,370
-4,500 Reduced 93.75%
300 $31,000
Q3 2020

Nov 13, 2020

BUY
$54.34 - $94.85 $260,832 - $455,280
4,800 New
4,800 $340,000
Q2 2020

Aug 13, 2020

SELL
$29.67 - $80.0 $140,487 - $378,800
-4,735 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$17.78 - $31.58 $84,188 - $149,531
4,735 New
4,735 $142,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Credit Agricole S A Portfolio

Follow Credit Agricole S A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.